RBR-3fthf8
Active, not recruiting
Phase 1
Clinical trial phase I/II to evaluate the safety, the neutralizing capacity and the lowest effective dose of antivenom for the treatment of multiple africanized honey bees stings Apis mellifera- APIS Study
Faculdade de Medicina de Botucatu0 sitesJuly 26, 2020
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Faculdade de Medicina de Botucatu
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Be aged over 18 and under 60 years of both sexes; having a diagnosis of crash with bees Apis; have the consent of the patient or family to receive antivenom.
Exclusion Criteria
- •Have had frequent contact with products of horse; have had previous adverse reaction to receiving the antivenom; to be pregnant; be with chronic disease, including congenital and acquired immunodeficiencies; introduce diseases that the combined use contraindication antihistamines, corticosteroids and potent analgesics, including allergic reaction.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/IIa trial of Ga-68 PSMA-11 produced on the MPS200 PSMA-Ga automated synthesizerJPRN-jRCT2022230014Shiga Tohru9
Active, not recruiting
Phase 1
Safety assessment and dose of fibrin sealant derived from snake venom in the treatment of wounds.RBR-9mbdj3Faculdade de Medicina de Botucatu - Unesp
Active, not recruiting
Phase 1
VAC079; a study to the assess the safety and efficacy of the malaria vaccine PvDBPII in Matrix M1EUCTR2019-002872-14-GBniversity of Oxford / Clinical Trials and Research Governance24
Active, not recruiting
Phase 1
A study to assess the new malaria vaccine RH5.1/AS01EUCTR2016-001718-31-GBniversity of Oxford, CTRG84
Not yet recruiting
Phase 1
CIGB-Mambisa/Abdala in convalescentsCOVID-19 ConvalescenceCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000382Center for Genetic Engineering and Biotechnology (CIGB)120